A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit Setting

What is the purpose of this trial?

The purpose of this study is to assess the efficacy of intravenous brivaracetam (BRV) compared to intravenous lorazepam (LZP) in subjects with epilepsy undergoing Epilepsy Monitoring Unit (EMU) evaluation who experience seizures that require prompt treatment.


Participation Guidelines

Ages: 18 - 70 years

Gender: Both


UCB Biopharma

Dates: 10/23/2017 - 06/30/2018

Last Updated: 10/24/2017

Study HIC#: 2000021003

Get Involved

For more information about this study, contact:
Ruby Tripathi
ruby.tripathi@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image

Investigators

Lawrence J. Hirsch

Principal Investigator

Sub-Investigators